ArticleACS medicinal chemistry letters2021

Discovery of Selective Transforming Growth Factor β Type II Receptor Inhibitors as Antifibrosis Agents.

Shohei Miwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.